or
forgot password

    • cancer clinical trials in east setauket, NY

    • Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    North Shore Hematology/Oncology Associates, P.C.
    East Setauket, New York 11733
    Colorectal Cancer
    Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
    StonyBrook Dermatology Associates, P.C.
    East Setauket, New York 11733
    Lymphoma
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    East Setauket, New York
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    North Shore Hematology/Oncology Associates
    East Setauket, New York
    Advanced Prostate Cancer, Prostatic Neoplasms
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    North Shore Hematology/Oncology Associates
    East Setauket, New York
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    National Translational Research Group, Inc.
    East Setauket, New York 11733
    Prostate Cancer
    Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
    North Shore Hematology/Oncology Associates, P.C.
    East Setauket, New York 11733
    Colorectal Cancer
    Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    North Shore Hematology/Oncology Associates, P.C.
    East Setauket, New York 11733
    Leukemia, Lymphoma
    Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    North Shore Hematology Oncology Associates
    East Setauket, New York 11733
    Prostate Cancer
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    North Shore Hematology Oncology Assoc., PC
    East Setauket, New York 11733
    Prostate Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    North Shore Hematology Oncology Associates, P.C.
    East Setauket, New York 11733
    Non Small Cell Lung Carcinoma
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    North Shore Hematology/Oncology Associates, P.C.
    East Setauket, New York 11733
    Non-Small Cell Lung Cancer
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    North Shore Hematology Oncology Associates P.C.
    East Setauket, New York 11733
    Prostate Cancer
    Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
    North Shore Hematology/Oncology Associates, PC
    East Setauket, New York 11733
    Multiple Myeloma
    A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
    North Shore Hematology Oncology Associates
    East Setauket, New York 11733
    Breast Cancer
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    North Shore Hematology
    East Setauket, New York 11733
    Colorectal Cancer Metastatic
    E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer
    North Shore Hematology/Oncology Associates
    East Setauket, New York
    Breast Cancer
    Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
    North Shore Hematology Oncology Associates
    East Setauket, New York 11733
    Metastatic Androgen Independent Prostate Cancer